Tarsus Pharmaceuticals, Inc. TARS
76.65 USD -2.03 (-2.58%)
As ofNov 17, 2026, 11:37 AM EST
76.18 Day range 78.19
53.89 52-week range 91.53
- YTD
- -6.39%
- 1 year
- +3.34%
News
benzinga.com Short Seller Flagged Nvidia China Worries Months Ago: Here’s How Much Stock Has Fallen Since A short report on Nvidia stock in May got mostly ignored. Six months later, it's getting increased attention for being right.benzinga.com Guggenheim Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $97 Guggenheim analyst Eddie Hickman maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and raises the price target from $89 to $97.
benzinga.com HC Wainwright & Co. Maintains Buy on Tarsus Pharmaceuticals, Raises Price Target to $106 HC Wainwright & Co. analyst Matthew Caufield maintains Tarsus Pharmaceuticals (NASDAQ:TARS) with a Buy and raises the price target from $88 to $106.
benzinga.com UPDATE: Tarsus Pharmaceuticals Q3 Adj. EPS $(0.78) Beats $(2.73) Estimate, Sales $194.569M Beat $186.598M Estimate Tarsus Pharmaceuticals (NASDAQ:TARS) reported quarterly losses of $(0.78) per share which beat the analyst consensus estimate of $(2.73) by 71.43 percent. This is a 160 percent decrease over losses…
benzinga.com Tarsus Pharmaceuticals Q3 2026 Earnings Call Transcript Tarsus Pharmaceuticals (NASDAQ:TARS) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is…
